B. NGF Therapeutic Potential Based on Human Diseases
Disease | Dose | Treatment | Side Effects | Outcome | Refs. |
---|---|---|---|---|---|
Neurotrophic keratitis | 10μg* | 4 weeks | None | Healed | [54] |
Immune cornea ulcer | 10μg* | 6-8 weeks | None | Healed | [14] |
Glaucoma | 10μg* | 12-15 weeks | None | Protective | [15] |
Maculopathy | 10μg* | 15-20 weeks | None | Protective | [16] |
Crush syndrome | 10μg** | 1 week | None | Protective | [97] |
Vasculitic ulcer | 20μg** | 20 weeks | None | Healed | [63] |
Pressure ulcer | 20μg** | 10 weeks | None | Healed | [22] |
Other | |||||
Diabetic neuropathy | 0.3μg*** | 3 weeks | Local pain | Protection? | [9] |